Insufficient scRNA-seq data for expression of HTR1A at single-cell level.
Insufficient scRNA-seq data for expression of HTR1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 49% | 60.63 | 1307 / 2642 | 46% | 2.85 | 324 / 705 |
ovary | 31% | 11.48 | 55 / 180 | 0% | 0.00 | 1 / 430 |
adrenal gland | 0% | 0.10 | 1 / 258 | 13% | 1.75 | 30 / 230 |
heart | 4% | 1.73 | 38 / 861 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 1% | 0.03 | 5 / 459 |
prostate | 1% | 0.18 | 2 / 245 | 0% | 0.01 | 1 / 502 |
skin | 0% | 0.02 | 2 / 1809 | 1% | 0.02 | 3 / 472 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.01 | 1 / 178 |
esophagus | 0% | 0 | 0 / 1445 | 1% | 0.01 | 1 / 183 |
lung | 0% | 0.03 | 1 / 578 | 0% | 0.01 | 2 / 1155 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.01 | 2 / 605 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.00 | 1 / 504 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.01 | 1 / 527 |
breast | 0% | 0 | 0 / 459 | 0% | 0.01 | 2 / 1118 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046883 | Biological process | regulation of hormone secretion |
GO_0035640 | Biological process | exploration behavior |
GO_0019229 | Biological process | regulation of vasoconstriction |
GO_0042053 | Biological process | regulation of dopamine metabolic process |
GO_0050795 | Biological process | regulation of behavior |
GO_0007210 | Biological process | serotonin receptor signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0001662 | Biological process | behavioral fear response |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0007198 | Biological process | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_0014062 | Biological process | regulation of serotonin secretion |
GO_0042428 | Biological process | serotonin metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0090722 | Molecular function | receptor-receptor interaction |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0051378 | Molecular function | serotonin binding |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | HTR1A |
Protein name | 5-hydroxytryptamine receptor 1A (Serotonin receptor 1A) 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A) 5-hydroxytryptamine receptor 1A |
Synonyms | ADRB2RL1 5HT1A hCG_16836 ADRBRL1 |
Description | FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores. Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism. Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior. Plays a role in the response to anxiogenic stimuli. . FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Beta-arrestin family members inhibit signaling via G proteins and mediate activation of alternative signaling pathways. Signaling inhibits adenylate cyclase activity and activates a phosphatidylinositol-calcium second messenger system that regulates the release of Ca(2+) ions from intracellular stores. Plays a role in the regulation of 5-hydroxytryptamine release and in the regulation of dopamine and 5-hydroxytryptamine metabolism. Plays a role in the regulation of dopamine and 5-hydroxytryptamine levels in the brain, and thereby affects neural activity, mood and behavior. Plays a role in the response to anxiogenic stimuli. . |
Accessions | ENST00000506598.1 ENST00000323865.5 Q5ZGX3 P08908 D6RA34 |